Credence Genomics
Credence Genomics is dedicated to developing advanced diagnostic tools using next-generation sequencing (NGS) technology to identify and treat infectious diseases, including sepsis and antimicrobial resistance (AMR). Their platform offers rapid, accurate, and comprehensive pathogen detection and antibiotic resistance profiling, aiming to improve clinical microbiology response and global health outcomes.
Industries
Nr. of Employees
small (1-50)
Credence Genomics
Kohuwala, Western, Sri Lanka, Asia
Products
NGS-based bacterial detection assay (clinical metagenomics)
Sequencing-based assay and analysis workflow for broad-spectrum detection of bacterial pathogens from clinical samples, with species-level identification and support for serotyping/genotyping.
NGS-based fungal detection assay (clinical metagenomics)
Sequencing assay and analysis pipeline for detection of fungal pathogens in acute and chronic infections, suitable for immunosuppressed patient monitoring.
NGS-based viral detection assay (DNA & RNA metagenomics)
Assay and pipeline for simultaneous detection of DNA and RNA viruses from clinical samples with species/genotype resolution.
Digital antimicrobial susceptibility testing (sequence-driven AST)
Computational product that provides resistance profiling and antibiotic guidance derived from sequencing data using machine learning models.
NGS-based bacterial detection assay (clinical metagenomics)
Sequencing-based assay and analysis workflow for broad-spectrum detection of bacterial pathogens from clinical samples, with species-level identification and support for serotyping/genotyping.
NGS-based fungal detection assay (clinical metagenomics)
Sequencing assay and analysis pipeline for detection of fungal pathogens in acute and chronic infections, suitable for immunosuppressed patient monitoring.
NGS-based viral detection assay (DNA & RNA metagenomics)
Assay and pipeline for simultaneous detection of DNA and RNA viruses from clinical samples with species/genotype resolution.
Digital antimicrobial susceptibility testing (sequence-driven AST)
Computational product that provides resistance profiling and antibiotic guidance derived from sequencing data using machine learning models.
Services
Clinical metagenomic diagnostic testing
Laboratory service performing NGS-based detection and reporting of bacterial, fungal and viral pathogens from clinical specimens with species/genotype-level output.
Digital antimicrobial susceptibility analysis (ML-driven)
Computational service that uses sequencing output and machine learning models to provide antibiotic resistance profiles and treatment guidance support.
Integration and deployment of near-care sequencing workflows
Support for integrating portable sequencing platforms into decentralized or near-patient settings to enable rapid, point-of-need pathogen detection.
Clinical validation and comparative study support
Design and execution of comparative studies and validation protocols comparing sequencing-based diagnostics to conventional culture and other methods, including metrics reporting (sensitivity, specificity, concordance).
Clinical metagenomic diagnostic testing
Laboratory service performing NGS-based detection and reporting of bacterial, fungal and viral pathogens from clinical specimens with species/genotype-level output.
Digital antimicrobial susceptibility analysis (ML-driven)
Computational service that uses sequencing output and machine learning models to provide antibiotic resistance profiles and treatment guidance support.
Integration and deployment of near-care sequencing workflows
Support for integrating portable sequencing platforms into decentralized or near-patient settings to enable rapid, point-of-need pathogen detection.
Clinical validation and comparative study support
Design and execution of comparative studies and validation protocols comparing sequencing-based diagnostics to conventional culture and other methods, including metrics reporting (sensitivity, specificity, concordance).
Expertise Areas
- Metagenomic NGS diagnostics
- Clinical diagnostic validation and comparative studies
- Bioinformatics and machine learning for infectious disease
- Digital antimicrobial susceptibility testing
Key Technologies
- Next-generation sequencing (NGS)
- Metagenomic sequencing
- 16S rRNA sequencing
- Nanopore sequencing